Health Library Logo

Health Library

Nephrogenic Systemic Fibrosis

Uhlolojikelele

I-nephrogenic systemic fibrosis yisifo esingavamile esihlala kakhulu kubantu abanesifo sokwehluleka kwesibindi esikhulile, kungakhathaliseki ukuthi banokwelashwa nge-dialysis noma cha. I-nephrogenic systemic fibrosis ingafana nezifo zesikhumba, njenge-scleroderma ne-scleromyxedema, lapho ukuqina nokukhanya kuvela ezindaweni ezinkulu zesikhumba.

I-nephrogenic systemic fibrosis ingathinta namanye amalungu omzimba, njengentliziyo nemiphunga, futhi ingabangela ukufinyeka okukhubaza imisipha nemisipha yemisipha ezinhlangothini (ukuncika kwamajozi).

Kubantu abanye abanesifo sesibindi esikhulile, ukubonisana nezikhali ze-gadolinium-based contrast agents (iqembu 1) ngesikhathi sokwenza i-magnetic resonance imaging (MRI) nezinye izifundo zokwenza izithombe kuye kwabonakala njengokuthinta ukuthuthukiswa kwalesi sifo. Ukuqaphela lobu buhlobo kuye kwancishisa kakhulu inani le-nephrogenic systemic fibrosis. Izidakamizwa ezintsha ze-gadolinium-based contrast agents (iqembu 2) azihambisani nokungena engozini enkulu ye-nephrogenic systemic fibrosis.

Izimpawu

I-nephrogenic systemic fibrosis ingaqala ezinsukwini ezimbalwa kuya ezinyangeni, ngisho naseminyakeni, ngemva kokubekwa ekuxhumaneni nomkhiqizo wokuhlola osekhulile obunomkhiqizo we-gadolinium (iqembu 1). Amanye ama-sign nama-symptoms e-nephrogenic systemic fibrosis angafaka:

  • Ukukhula nokuqina kwesikhumba
  • Izicucu ezibomvu noma ezimnyama esikhumbeni
  • Ukukhuluphala nokuqina kwesikhumba, ngokuvamile ezingalweni nasemiileni, ngezinye izikhathi emzimbeni, kodwa cishe akukaze kube ebusweni noma ekhanda
  • Isikhumba esingase sizizwe "njengomgqomo" futhi sibe nobukhulu obubomvu
  • Ukushisa, ukukhahlela noma ubuhlungu obukhulu obukhulu ezindaweni ezihilelekile
  • Ukukhuluphala kwesikhumba okuvimba ukunyakaza, okuholela ekwehleni kokuguquguquka kwamajozi
  • Ngokungavamile, ama-blisters noma ama-ulcers

Kwabanye abantu, ukuhileleka kwemisipha nezingxenye zomzimba kungabangela:

  • Ubuthakathaka bemisipha
  • Ukulinganiselwa kokunyakaza kwamajozi okubangelwa ukuqina kwemisipha (ama-contractures) ezingalweni, ezandleni, ezinyaweni nasezinyaweni
  • Ubuhlungu lwamathambo, ikakhulukazi emathanjeni noma eziphahleni
  • Ukusebenza okunciphisiwe kwezingxenye zomzimba yangaphakathi, kufaka phakathi inhliziyo, amaphaphu, i-diaphragm, umgudu wokugaya ukudla noma isibindi
  • Ama-plaque aphuzi ebusweni obumhlophe (sclera) amehlo

Isimo ngokuvamile sihlala isikhathi eside (esingapheli), kodwa abanye abantu bangase bathuthuke. Kubantu abambalwa, kungabangela ukukhubazeka okukhulu, ngisho nokufa.

Izimbangela

Imbangela eqondile ye-nephrogenic systemic fibrosis ayiqondakali ngokuphelele. I-fibrous connective tissue yakha oluswini nakwi-connective tissues, okuholela ekwenzakaleni kwezicubu emzimbeni wonke, ikakhulu oluswini nakwi-subcutaneous tissues.

Ukubonisana ne-gadolinium-based contrast agents endala (iqembu 1) ngesikhathi se-magnetic resonance imaging (MRI) kuye kwabonakala njengokuthinta ukuthuthukiswa kwalesi sifo kubantu abanesifo sezinso. Lo mongo wokwanda kuthiwa uxhumekile ekubeni izinso zinekhono eliphansi lokususa i-contrast agent egazini.

I-Food and Drug Administration (FDA) iphakamisa ukugwema i-gadolinium-based contrast agents endala (iqembu 1) kubantu abanesifo sezinso esibuhlungu noma i-chronic kidney disease.

Ezinye izimo zingandisa ingozi ye-nephrogenic systemic fibrosis uma zidibene nesifo sezinso esikhoyo nokubonisana ne-gadolinium-based contrast agents endala (iqembu 1), kodwa uxhumano alucaci. Lezi zihlanganisa:

  • Ukusetshenziswa kwe-high-dose erythropoietin (EPO), i-hormone ekhuthaza ukukhiqizwa kwamaseli ebomvu egazi, evame ukusetshenziswa ekwelapheni i-anemia
  • Ukuhlinzwa kwesicubu segagasi samuva nje
  • Izinkinga zokugqwala kwegazi
  • Ukutheleleka okukhulu
Izici eziyingozi

Ingozi enkulu kunazo zonke ye-nephrogenic systemic fibrosis ngemva kokubekwa ezingozini ze-gadolinium-based contrast agents (iqembu 1) kwenzeka kubantu abalandelayo:

  • Abane-kidney disease ephakathi nendawo
  • Abake baba nokuhlinzwa kwe-kidney kodwa banokusebenza okungathandeki kwe-renal
  • Abathola i-hemodialysis noma i-peritoneal dialysis
  • Abane-acute kidney injury
Ukuvimbela

Ukugwema ukusetshenziswa kwezinto ezikhuthazayo ezikhuluma i-gadolinium ezindala (iqembu 1) kubalulekile ekuvinjeni i-nephrogenic systemic fibrosis, njengoba izinto ezikhuthazayo ezikhuluma i-gadolinium ezintsha (iqembu 2) ziphephile futhi azixhunyaniswanga nenkinga eyenzeka ngokwanda.

Ukuxilongwa

Ukuxilongwa kwe-nephrogenic systemic fibrosis kwenziwa ngokusebenzisa:

  • Uvivinyo lomzimba lokuqaphela izimpawu nezibonakaliso zesifo, kanye nokulinganisa umlando onokwenzeka we-MRI usebenzisa i-gadolinium-based contrast agent uma kukhona isifo esithuthukile sezinso
  • Isibonelo sethusi (i-biopsy) esithathwe oluswini nakemisipha
  • Ezinye izivivinyo ezidingekayo ezingabonisa ukuhileleka kwemisipha namalungu angaphakathi
Ukwelashwa

Asikho ukwelashwa kwe-nephrogenic systemic fibrosis, futhi asikho ukwelashwa okuphumelelayo ngokuqhubekayo ekuqedeni noma ekuphenduleni intuthuko yesifo. I-Nephrogenic systemic fibrosis ivele kancane, okwenza kube nzima ukuqhuba izifundo ezinkulu.

Ezinye izindlela zokwelapha zibonise impumelelo encane kubantu abane-nephrogenic systemic fibrosis, kodwa ucwaningo olwengeziwe luyadingeka ukuze kutholakale ukuthi lezi zindlela zokwelapha ziyasiza yini:

  • Ukuhlanzwa kwegazi (Hemodialysis). Kubantu abanesifo esibi sokwehluleka kwesibindi esikade sikhonjiswe abamukela ukuhlanzwa kwegazi, ukuqhuba ukuhlanzwa kwegazi ngokushesha ngemva kokwamukela i-gadolinium-based contrast agent kunganciphisa amathuba e-nephrogenic systemic fibrosis.
  • Ukwelashwa komzimba (Physical therapy). Ukwelashwa komzimba okusiza ekuqinisweni kwamahlathi ahilelekile kungasiza ekuthambiseni intuthuko ye-joint contractures futhi kulondoloze ukunyakaza.
  • Ukuhlinzwa kwesibindi (Kidney transplant). Kubantu abafanelekela, ukuthuthuka kokusebenza kwesibindi ngenxa yokuhlinzwa kwesibindi kungasiza ekuthuthukiseni i-nephrogenic systemic fibrosis ngokuhamba kwesikhathi.
  • I-Extracorporeal photopheresis nge-ultraviolet A. Lolu lwelo lwela luhilela ukukhipha igazi ngaphandle komzimba nokuphatha igazi ngemithi elikwenza libe nomuzwa ekukhanyeni kwe-ultraviolet. Igazi bese lifakwa ekukhanyeni kwe-ultraviolet bese libuyiselwa emzimbeni. Abanye abantu baye babonisa ukuthuthuka ngemva kokwamukela le therapy.

Le miyekezo iyocwaningo, kodwa ayisetshenziswanga njengamanje. Ibonise ukuthi iyabasiza abanye abantu, kodwa imiphumela emibi iyancipha ukusetshenziswa kwayo:

  • Imatinib (Gleevec). Nakuba lolu lwelo lubonisa ithemba ekuthambiseni nokuqinisa kwesikhumba, ucwaningo olwengeziwe luyadingeka.
  • Pentoxifylline (Pentoxil). Kunempumelelo encane ngale miyekezo, ngokwezindlela ezingokombono inciphisa ubukhulu nokunamathela (viscosity) kwegazi, kusiza ukujikeleza. Ucwaningo olwengeziwe luyadingeka.
  • I-Sodium thiosulfate. Ukuzuza okungenzeka kubonisiwe ngokusebenzisa le miyekezo, kodwa ucwaningo olwengeziwe luyadingeka.
  • I-High-dose intravenous immune globulin. Ukuzuza okungenzeka kubonisiwe ngokusebenzisa le miyekezo, kodwa ucwaningo olwengeziwe luyadingeka.

Ikheli: 506/507, 1st Main Rd, Murugeshpalya, K R Garden, Bengaluru, Karnataka 560075

Umshwana wokuzihlangula: I-August iyinkundla yolwazi lwezempilo futhi izimpendulo zayo azihlanganisi iseluleko sezokwelapha. Njalo thintana nochwepheshe bezokwelapha onelayisensi eduze nawe ngaphambi kokwenza noma yiluphi ushintsho.

Yenziwe eNdiya, yomhlaba